CytoSorb® is CE-mark approved in the E.U. In the U.S., CytoSorb® and DrugSorb-ATR® are investigational devices not yet FDA authorized/approved/cleared.
Content dedicated only to Investor Relationsback to cytosorbents.com

Investor Relations
CytoSorbents

Cytosorbents to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference

We are pleased to announce thatCytosorbents Corp. has been invited to participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference, taking place on August 11–12, 2025.

This virtual event brings together leading companies and institutional investors in the MedTech and Diagnostics sectors. Cytosorbents will have the opportunity to engage in one-on-one meetings with top-tier investors through Needham’s virtual meeting platform.